CareCloud, Inc. Form 8-K Summary
Business Context and Reporting Period
CareCloud, Inc. (CCLD) filed this Current Report on Form 8-K on April 13, 2026, to disclose the entry into material definitive agreements and the election to redeem its Series B Preferred Stock. The company is incorporated in Delaware and trades on the Nasdaq Global Market.
Key Financial Metrics and Agreements
- Debt Financing: Entered into a Credit Agreement establishing a $40.0 million term loan and a $10.0 million revolving credit facility (total $50.0 million).
- Debt Terms: Facilities mature on the fourth anniversary of closing. The term loan amortizes in equal monthly installments starting June 1, 2026. Interest rates are based on Term SOFR, Daily Simple SOFR, or alternate base rate plus an applicable margin.
- Collateral: Obligations are secured by substantially all company assets and guaranteed by subsidiaries. Executive Chairman Mahmud Haq will pledge securities accounts as additional collateral.
- Equity Financing: Entered an At-The-Market (ATM) Offering Agreement allowing the sale of up to $60.0 million of common stock. The sales agent receives a 3.0% commission.
- Preferred Stock Redemption: Elected to redeem all 1,511,372 outstanding shares of 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock.
- Redemption Cost: Total payment of $27.52 per share ($25.25 redemption price + $2.27 accrued dividends), totaling approximately $41.59 million.
Material Changes and Transactions
The primary material change is the restructuring of the company's capital structure. The company is replacing its perpetual preferred stock obligation with a senior secured credit facility and establishing a new equity sales mechanism. The proceeds from the $50.0 million credit facility are explicitly designated for general corporate purposes, including the redemption of the Series B Preferred Stock.
Outlook, Risks, and Unusual Items
- Management Commentary: Proceeds from the ATM offering will be used for general corporate purposes, including potential acquisitions, loan repayments, organic growth, capital expenditures, and working capital.
- Executive Compensation/Incentive: In consideration for the Executive Chairman's pledge of securities accounts, he will receive a warrant for 4,300,000 shares of common stock at a strike price of $5.00 per share. The warrant has a five-year term and includes anti-dilution provisions.
- Risks: The filing contains forward-looking statements regarding future financial performance and financing arrangements. Actual results may differ due to various risks and uncertainties.
- Unusual Items: The redemption of the preferred stock will cease dividend accumulation on these shares effective May 15, 2026.
Investor Verification Checklist
- Verify the exact closing date and funding of the $50.0 million Credit Facility.
- Confirm the execution of the Securities Account Pledge Agreement and the issuance of the 4.3 million share warrant to the Executive Chairman.
- Monitor the redemption payment date of May 15, 2026, and the subsequent delisting of the Series B Preferred Stock (CCLDO).
- Review the specific interest rate margins and financial covenants detailed in the definitive Credit Agreement (Exhibit 10.1).
- Track the utilization of the $60.0 million ATM facility and the impact of potential dilution on common shareholders.